Your browser doesn't support javascript.
loading
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial.
Ravandi, Farhad; Roboz, Gail J; Wei, Andrew H; Döhner, Hartmut; Pocock, Christopher; Selleslag, Dominik; Montesinos, Pau; Sayar, Hamid; Musso, Maurizio; Figuera-Alvarez, Angela; Safah, Hana; Tse, William; Sohn, Sang Kyun; Hiwase, Devendra; Chevassut, Timothy; Pierdomenico, Francesca; La Torre, Ignazia; Skikne, Barry; Bailey, Rochelle; Zhong, Jianhua; Beach, C L; Dombret, Herve.
Afiliação
  • Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. fravandi@mdanderson.org.
  • Roboz GJ; Weill Cornell Medicine, New York, NY, USA.
  • Wei AH; New York Presbyterian Hospital, New York, NY, USA.
  • Döhner H; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia.
  • Pocock C; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
  • Selleslag D; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
  • Montesinos P; Kent & Canterbury Hospital, Canterbury, UK.
  • Sayar H; AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium.
  • Musso M; Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Figuera-Alvarez A; Indiana University Cancer Center, Indianapolis, IN, USA.
  • Safah H; La Maddalena - Casa di Cura, Palermo, Italy.
  • Tse W; Hospital Universitario de La Princesa, Madrid, Spain.
  • Sohn SK; Tulane University Health Science Center, New Orleans, LA, USA.
  • Hiwase D; University of Louisville School of Medicine, Louisville, KY, USA.
  • Chevassut T; Kyungpook National University Hospital, Daegu, Korea.
  • Pierdomenico F; Royal Adelaide Hospital, Adelaide, Australia.
  • La Torre I; Brighton and Sussex Medical School, Brighton, UK.
  • Skikne B; Portuguese Institute of Oncology Lisbon, Lisbon, Portugal.
  • Bailey R; Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland.
  • Zhong J; University of Kansas Medical Center, Kansas City, KS, USA.
  • Beach CL; Bristol Myers Squibb, Princeton, NJ, USA.
  • Dombret H; Bristol Myers Squibb, Princeton, NJ, USA.
J Hematol Oncol ; 14(1): 133, 2021 08 28.
Article em En | MEDLINE | ID: mdl-34454540
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article